Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| May 31st, 2021 |
U.S. Ambassador's President's Emergency Plan for AIDS Relief (PEPFAR) Small Grants Program Financial Year (FY) 2021 - 022 |
US Mission to Malawi |
| July 29th, 2021 |
Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed) |
National Institutes of Health |
| May 4th, 2021 |
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 |
National Institutes of Health |
| July 29th, 2021 |
Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2022 (R24 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 31st, 2021 |
PEPFAR Grants for Community-Led Monitoring |
US Mission to Nigeria |
| May 21st, 2021 |
Rural Residency Planning and Development Technical Assistance Program |
Health Resources and Services Administration |
| July 20th, 2021 |
Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) |
National Institutes of Health |
| September 27th, 2023 |
National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) |
National Institutes of Health |
| June 9th, 2021 |
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| August 10th, 2021 |
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) |
National Institutes of Health |
| October 24th, 2023 |
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2024 |
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required) |
National Institutes of Health |
| April 29th, 2021 |
Local Works in the Kyrgyz Republic |
Kazakhstan USAID Almaty |
| August 4th, 2021 |
Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| July 30th, 2021 |
Understanding HIV Reservoir Dynamics (P01, Clinical Trial Not Allowed) |
National Institutes of Health |
| August 10th, 2021 |
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed) |
National Institutes of Health |
| April 23rd, 2021 |
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| October 20th, 2021 |
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 26th, 2022 |
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 15th, 2021 |
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required) |
National Institutes of Health |
|
| May 20th, 2021 |
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| June 1st, 2021 |
Public Diplomacy Grants in Kuwait |
US Mission to Kuwait |
| May 17th, 2021 |
Screening and Interventions for Adverse Childhood Experiences in Primary Care Settings Demonstration Project |
Health Resources and Services Administration |
| May 7th, 2024 |
NINDS Program Project Grant (P01 Clinical Trial Optional) |
National Institutes of Health |
| November 10th, 2021 |
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) |
National Institutes of Health |
| November 10th, 2021 |
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 15th, 2021 |
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) |
National Institutes of Health |
| November 15th, 2021 |
Specialized Alcohol Research Centers (P50 Clinical Trial Optional) |
National Institutes of Health |
| January 29th, 2024 |
Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
| August 17th, 2021 |
Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) |
National Institutes of Health |
| November 8th, 2021 |
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 10th, 2021 |
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) |
National Institutes of Health |
| March 1st, 2022 |
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
| July 15th, 2021 |
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 30th, 2021 |
Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 12th, 2023 |
Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials) |
National Institutes of Health |
| July 30th, 2021 |
Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 30th, 2021 |
Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 1st, 2021 |
Preventive Health and Health Services Block Grant- 2021 |
Centers for Disease Control OSTLTS |
| September 7th, 2021 |
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
